Online Database of Chemicals from Around the World Search | Submit | Advertise

Home >> Chemical Listing >> Basimglurant>> Market Analysis Reports
 

Market Analysis Reports of Basimglurant

Global Major Depressive Disorder Drug Market Report 2020
... Segmentation Aripiprazole AV-101 AVP-786 Basimglurant Brexpiprazole Industry Segmentation Hospital Clinic ...

Global Major Depressive Disorder Drug Market Growth 2024-2030
... by type Aripiprazole AV-101 AVP-786 Basimglurant Brexpiprazole Others Segmentation by application Hospital ...

Global Major Depressive Disorder Drug Market Growth 2025-2031
... by Type: Aripiprazole AV-101 AVP-786 Basimglurant Brexpiprazole Others Segmentation by Application: Hospital ...

Global Major Depressive Disorder Drug Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
... by Type Aripiprazole AV-101 AVP-786 Basimglurant Brexpiprazole Others Market segment by Application ...

Major depressive disorder - Pipeline Review, 2019
... /samidorphan Zuranolone Buprenorphine + samidorphan Gepirone ER Basimglurant Apimostinel Esketamine BTRX 246040 NV 5138 ...

Global Major Depressive Disorder Drug Market Status, Trends and COVID-19 Impact Report 2021
... Segmentation Aripiprazole AV-101 AVP-786 Basimglurant Brexpiprazole Application Segmentation Hospital Clinic ...

Major Depressive Disorder Drug Market, Global Outlook and Forecast 2022-2028
... , 2021 (%) Aripiprazole AV-101 AVP-786 Basimglurant Brexpiprazole Others Global Major Depressive ...

Trigeminal Neuralgia (Tic Douloureux) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Trigeminal Neuralgia (Tic Douloureux) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Trigeminal Neuralgia - Drugs in ...

Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY According to the recently published report 'Metabotropic Glutamate Receptor 5 - Drugs In ...

Trigeminal Neuralgia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
The 7 major trigeminal neuralgia markets reached a value of US$ 234.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 357.8 Million by 2034, exhibiting a growth rate (CAGR) of 3.92% during 2024-2034. The trigeminal neuralgia ...

Global Major Depressive Disorder Drug Market Research Report 2024(Status and Outlook)
... (by Type) Aripiprazole AV-101 AVP-786 Basimglurant Brexpiprazole Others Market Segmentation (by Application ...

Global Metabotropic Glutamate Receptor 5 Market Research Report 2025(Status and Outlook)
... mixed clinical outcomes (e.g., the discontinuation of basimglurant for depression) temper market expansion ...




Copyright ©  chemBlink. All rights reserved. Content Disclaimer | about chemBlink | Contact